Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"EC 2.7.10.1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%221354-3784%22+OR+%221744-7658%22&type=ISN&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
/vufind/Search/Results?lookfor=%221354-3784%22+OR+%221744-7658%22&type=ISN&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
Search /vufind/Search2/Results?lookfor=%221354-3784%22+OR+%221744-7658%22&type=ISN&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22
PubPharm (171)
1
KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors : getting to the gist of the problem
enthalten in:
Expert opinion on investigational drugs
| 2024
von
Cicala, C.
|
Olivares-Rivas, I.
|
Aguirre-Carrillo, J.
| +1
Wird geladen...
2
Deterministic reprogramming and signaling activation following targeted therapy in non-small cell lung cancer driven by mutations or oncogenic fusions
enthalten in:
Expert opinion on investigational drugs
| 2024
von
Rosell, R.
|
Pedraz-Valdunciel, C.
|
Jain, A.
| +2
Wird geladen...
3
Taletrectinib for the treatment of ROS-1 positive non-small cell lung cancer : a drug evaluation of phase I and II data
enthalten in:
Expert opinion on investigational drugs
| 2024
von
Nagasaka, M.
|
Brazel, D.
|
Ou, S.
Wird geladen...
4
Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects : a phase I human radiolabeled mass balance study
enthalten in:
Expert opinion on investigational drugs
| 2024
von
Bian, Y.
|
Ma, S.
|
Yao, Q.
| +11
Wird geladen...
5
Experimental drugs in clinical trials for acute myeloid leukemia : innovations, trends, and opportunities
enthalten in:
Expert opinion on investigational drugs
| 2023
von
Gołos, A.
|
Góra-Tybor, J.
|
Robak, T.
Wird geladen...
6
A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Cho, B.
|
Goldberg, S.
|
Kim, D.
| +10
Wird geladen...
7
Tucatinib : an investigational novel therapeutic agent for the treatment of HER-2 colorectal cancer
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Ahn, D.
|
Walden, D.
|
Bekaii-Saab, T.
Wird geladen...
8
FGFR4 inhibitors for the treatment of hepatocellular carcinoma : a synopsis of therapeutic potential
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Xie, H.
|
Alem Glison, D.
|
Kim, R.
Wird geladen...
9
Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Tang, S.
|
Yu, Q.
|
Ding, C.
Wird geladen...
10
Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Lote, H.
|
Chau, I.
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: EC 2.7.10.1
Medienart
171
Aufsätze
157
E-Artikel
157
E-Ressourcen
14
Gedruckte Aufsätze
Zeitschriftentitel
171
Expert opinion on investigational drugs
Thema
EC 2.7.10.1
166
Journal Article
151
Review
97
Antineoplastic Agents
89
Protein Kinase Inhibitors
37
ErbB Receptors
34
Protein-Tyrosine Kinases
31
Research Support, Non-U.S. Gov't
29
Angiogenesis Inhibitors
23
Drugs, Investigational
21
Receptor, ErbB-2
20
Antibodies, Monoclonal
20
EC 2.7.10.2
16
Pyrimidines
16
Quinazolines
16
Receptor Protein-Tyrosine Kinases
16
Receptors, Vascular Endothelial Growth Factor
16
Vascular Endothelial Growth Factor A
12
ERBB2 protein, human
12
Proto-Oncogene Proteins c-met
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
22
2020-
101
2010-2019
41
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
171
Englisch
Haven't found what you're looking for?
Wird geladen...